Phase I trial of multiple oral doses of CK 2017357 in healthy male volunteers.

Trial Profile

Phase I trial of multiple oral doses of CK 2017357 in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Dec 2010

At a glance

  • Drugs Tirasemtiv (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Cytokinetics
  • Most Recent Events

    • 13 Dec 2010 Results presented earlier in the year ,according to a Cytokinetics media release
    • 22 Jul 2010 Results reported in a Cytokinetics media release.
    • 27 Jan 2010 Results reported in a Cytokinetics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top